Boston Scientific Corporation (BSX)
USD 88.03
(-2.65%)
USD 88.03
(-2.65%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 7.47 Billion USD | 12.52% |
| 2022 | 6.64 Billion USD | 5.43% |
| 2021 | 6.3 Billion USD | 10.23% |
| 2020 | 5.71 Billion USD | -1.63% |
| 2019 | 5.81 Billion USD | 10.09% |
| 2018 | 5.28 Billion USD | 8.75% |
| 2017 | 4.85 Billion USD | 6.4% |
| 2016 | 4.56 Billion USD | 7.54% |
| 2015 | 4.24 Billion USD | 2.09% |
| 2014 | 4.15 Billion USD | 5.37% |
| 2013 | 3.94 Billion USD | 3.38% |
| 2012 | 3.81 Billion USD | 17.34% |
| 2011 | 3.25 Billion USD | -22.88% |
| 2010 | 4.21 Billion USD | -34.21% |
| 2009 | 6.41 Billion USD | -8.94% |
| 2008 | 7.03 Billion USD | 22.04% |
| 2007 | 5.76 Billion USD | 29.79% |
| 2006 | 4.44 Billion USD | 21.65% |
| 2005 | 3.65 Billion USD | 35.65% |
| 2004 | 2.69 Billion USD | 51.21% |
| 2003 | 1.78 Billion USD | 31.54% |
| 2002 | 1.35 Billion USD | -1.31% |
| 2001 | 1.37 Billion USD | 10.02% |
| 2000 | 1.24 Billion USD | 2.47% |
| 1999 | 1.21 Billion USD | -32.28% |
| 1998 | 1.79 Billion USD | 80.83% |
| 1997 | 993.8 Million USD | 27.31% |
| 1996 | 780.6 Million USD | 43.23% |
| 1995 | 545 Million USD | 228.71% |
| 1994 | 165.8 Million USD | 20.49% |
| 1993 | 137.6 Million USD | 24.52% |
| 1992 | 110.5 Million USD | 36.25% |
| 1991 | 81.1 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 1.95 Billion USD | -0.36% |
| 2024 Q3 | 2.17 Billion USD | 17.74% |
| 2024 Q2 | 1.83 Billion USD | -5.94% |
| 2023 Q2 | 1.92 Billion USD | 8.89% |
| 2023 Q4 | 1.96 Billion USD | 8.58% |
| 2023 Q1 | 1.76 Billion USD | 4.37% |
| 2023 Q3 | 1.8 Billion USD | -6.08% |
| 2023 FY | 7.47 Billion USD | 12.52% |
| 2022 Q4 | 1.69 Billion USD | 1.14% |
| 2022 FY | 6.64 Billion USD | 5.43% |
| 2022 Q3 | 1.67 Billion USD | -1.82% |
| 2022 Q1 | 1.57 Billion USD | -5.29% |
| 2022 Q2 | 1.7 Billion USD | 8.05% |
| 2021 Q2 | 1.59 Billion USD | 8.04% |
| 2021 Q1 | 1.48 Billion USD | -1.79% |
| 2021 Q4 | 1.66 Billion USD | 6.73% |
| 2021 Q3 | 1.56 Billion USD | -2.44% |
| 2021 FY | 6.3 Billion USD | 10.23% |
| 2020 FY | 5.71 Billion USD | -1.63% |
| 2020 Q1 | 1.47 Billion USD | -7.68% |
| 2020 Q2 | 1.23 Billion USD | -16.36% |
| 2020 Q3 | 1.49 Billion USD | 20.94% |
| 2020 Q4 | 1.5 Billion USD | 0.74% |
| 2019 Q3 | 1.49 Billion USD | 6.17% |
| 2019 FY | 5.81 Billion USD | 10.09% |
| 2019 Q4 | 1.6 Billion USD | 7.09% |
| 2019 Q2 | 1.4 Billion USD | 7.64% |
| 2019 Q1 | 1.3 Billion USD | -6.7% |
| 2018 FY | 5.28 Billion USD | 8.75% |
| 2018 Q3 | 1.3 Billion USD | -0.08% |
| 2018 Q2 | 1.3 Billion USD | 3.65% |
| 2018 Q1 | 1.26 Billion USD | -2.32% |
| 2018 Q4 | 1.4 Billion USD | 7.35% |
| 2017 Q2 | 1.2 Billion USD | 2.47% |
| 2017 FY | 4.85 Billion USD | 6.4% |
| 2017 Q3 | 1.19 Billion USD | -0.67% |
| 2017 Q4 | 1.29 Billion USD | 8.3% |
| 2017 Q1 | 1.17 Billion USD | -4.33% |
| 2016 Q2 | 1.13 Billion USD | 6.97% |
| 2016 Q1 | 1.06 Billion USD | -8.13% |
| 2016 FY | 4.56 Billion USD | 7.54% |
| 2016 Q3 | 1.14 Billion USD | 0.35% |
| 2016 Q4 | 1.22 Billion USD | 7.46% |
| 2015 Q1 | 973 Million USD | -9.24% |
| 2015 Q2 | 1.03 Billion USD | 6.47% |
| 2015 Q3 | 1.08 Billion USD | 4.34% |
| 2015 Q4 | 1.15 Billion USD | 6.94% |
| 2015 FY | 4.24 Billion USD | 2.09% |
| 2014 FY | 4.15 Billion USD | 5.37% |
| 2014 Q4 | 1.07 Billion USD | 0.94% |
| 2014 Q3 | 1.06 Billion USD | 0.38% |
| 2014 Q2 | 1.05 Billion USD | 9.52% |
| 2014 Q1 | 966 Million USD | -7.65% |
| 2013 Q4 | 1.04 Billion USD | 7.17% |
| 2013 Q1 | 938 Million USD | -4.19% |
| 2013 Q2 | 985 Million USD | 5.01% |
| 2013 FY | 3.94 Billion USD | 3.38% |
| 2013 Q3 | 976 Million USD | -0.91% |
| 2012 Q2 | 1 Billion USD | -0.98% |
| 2012 Q1 | 1.01 Billion USD | 0.2% |
| 2012 FY | 3.81 Billion USD | 17.34% |
| 2012 Q4 | 979 Million USD | 8.06% |
| 2012 Q3 | 906 Million USD | -10.21% |
| 2011 FY | 3.25 Billion USD | -22.88% |
| 2011 Q1 | 231 Million USD | -72.17% |
| 2011 Q2 | 1.01 Billion USD | 338.53% |
| 2011 Q3 | 983 Million USD | -2.96% |
| 2011 Q4 | 1.01 Billion USD | 3.46% |
| 2010 Q3 | 1.03 Billion USD | -1.43% |
| 2010 Q1 | 1.06 Billion USD | -58.85% |
| 2010 Q2 | 1.04 Billion USD | -1.23% |
| 2010 Q4 | 830 Million USD | -19.57% |
| 2010 FY | 4.21 Billion USD | -34.21% |
| 2009 Q1 | 1.36 Billion USD | 119.39% |
| 2009 Q4 | 2.57 Billion USD | 147.22% |
| 2009 Q3 | 1.04 Billion USD | -7.71% |
| 2009 Q2 | 1.12 Billion USD | -17.53% |
| 2009 FY | 6.41 Billion USD | -8.94% |
| 2008 Q4 | 624 Million USD | -59.3% |
| 2008 Q3 | 1.53 Billion USD | 40.51% |
| 2008 Q2 | 1.09 Billion USD | -0.27% |
| 2008 Q1 | 1.09 Billion USD | -37.77% |
| 2008 FY | 7.03 Billion USD | 22.04% |
| 2007 FY | 5.76 Billion USD | 29.79% |
| 2007 Q4 | 1.75 Billion USD | 13.79% |
| 2007 Q3 | 1.54 Billion USD | 25.0% |
| 2007 Q2 | 1.23 Billion USD | 0.0% |
| 2007 Q1 | 1.23 Billion USD | -1.36% |
| 2006 Q4 | 1.25 Billion USD | 4.33% |
| 2006 Q3 | 1.2 Billion USD | -3.22% |
| 2006 Q2 | 1.24 Billion USD | 65.69% |
| 2006 Q1 | 749 Million USD | 2.18% |
| 2006 FY | 4.44 Billion USD | 21.65% |
| 2005 Q4 | 733 Million USD | -51.26% |
| 2005 Q3 | 1.5 Billion USD | 105.75% |
| 2005 Q2 | 731 Million USD | 6.72% |
| 2005 FY | 3.65 Billion USD | 35.65% |
| 2005 Q1 | 685 Million USD | -10.69% |
| 2004 Q2 | 585 Million USD | 11.22% |
| 2004 Q4 | 767 Million USD | -5.89% |
| 2004 FY | 2.69 Billion USD | 51.21% |
| 2004 Q1 | 526 Million USD | 9.13% |
| 2004 Q3 | 815 Million USD | 39.32% |
| 2003 Q4 | 482 Million USD | 6.64% |
| 2003 Q2 | 434 Million USD | 5.08% |
| 2003 Q1 | 413 Million USD | 5.9% |
| 2003 FY | 1.78 Billion USD | 31.54% |
| 2003 Q3 | 452 Million USD | 4.15% |
| 2002 FY | 1.35 Billion USD | -1.31% |
| 2002 Q4 | 390 Million USD | 47.17% |
| 2002 Q3 | 265 Million USD | -25.56% |
| 2002 Q2 | 356 Million USD | 3.79% |
| 2002 Q1 | 343 Million USD | 351.32% |
| 2001 Q2 | 362 Million USD | 15.65% |
| 2001 Q4 | 76 Million USD | -78.53% |
| 2001 FY | 1.37 Billion USD | 10.02% |
| 2001 Q1 | 313 Million USD | -19.33% |
| 2001 Q3 | 354 Million USD | -2.21% |
| 2000 Q3 | 287 Million USD | 0.35% |
| 2000 Q1 | 286 Million USD | -22.91% |
| 2000 Q2 | 286 Million USD | 0.0% |
| 2000 FY | 1.24 Billion USD | 2.47% |
| 2000 Q4 | 388 Million USD | 35.19% |
| 1999 Q1 | 279 Million USD | -74.71% |
| 1999 Q4 | 371 Million USD | 27.49% |
| 1999 Q3 | 291 Million USD | 5.43% |
| 1999 Q2 | 276 Million USD | -1.08% |
| 1999 FY | 1.21 Billion USD | -32.28% |
| 1998 FY | 1.79 Billion USD | 80.83% |
| 1998 Q1 | 223.2 Million USD | -41.15% |
| 1998 Q2 | 236.9 Million USD | 6.14% |
| 1998 Q3 | 247 Million USD | 4.26% |
| 1998 Q4 | 1.1 Billion USD | 346.72% |
| 1997 Q4 | 379.3 Million USD | 76.91% |
| 1997 FY | 993.8 Million USD | 27.31% |
| 1997 Q1 | 178.1 Million USD | -46.31% |
| 1997 Q2 | 203.4 Million USD | 14.21% |
| 1997 Q3 | 214.4 Million USD | 5.41% |
| 1996 Q1 | 133.7 Million USD | -54.43% |
| 1996 Q4 | 331.7 Million USD | 102.13% |
| 1996 Q3 | 164.1 Million USD | 8.68% |
| 1996 Q2 | 151 Million USD | 12.94% |
| 1996 FY | 780.6 Million USD | 43.23% |
| 1995 Q3 | 88.5 Million USD | 3.03% |
| 1995 Q4 | 293.4 Million USD | 231.53% |
| 1995 FY | 545 Million USD | 228.71% |
| 1995 Q1 | 77.1 Million USD | 56.39% |
| 1995 Q2 | 85.9 Million USD | 11.41% |
| 1994 Q4 | 49.3 Million USD | 25.77% |
| 1994 Q2 | 39.2 Million USD | 2.62% |
| 1994 Q1 | 38.2 Million USD | 11.7% |
| 1994 Q3 | 39.2 Million USD | 0.0% |
| 1994 FY | 165.8 Million USD | 20.49% |
| 1993 Q1 | 33.1 Million USD | 16.96% |
| 1993 Q2 | 35.3 Million USD | 6.65% |
| 1993 Q3 | 35 Million USD | -0.85% |
| 1993 Q4 | 34.2 Million USD | -2.29% |
| 1993 FY | 137.6 Million USD | 24.52% |
| 1992 FY | 110.5 Million USD | 36.25% |
| 1992 Q4 | 28.3 Million USD | -2.41% |
| 1992 Q3 | 29 Million USD | 6.23% |
| 1992 Q2 | 27.3 Million USD | 5.41% |
| 1992 Q1 | 25.9 Million USD | 116.24% |
| 1991 Q1 | - USD | 0.0% |
| 1991 Q4 | -159.5 Million USD | 0.0% |
| 1991 Q3 | - USD | 0.0% |
| 1991 FY | 81.1 Million USD | 0.0% |
| 1991 Q2 | - USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Abbott Laboratories | 15.71 Billion USD | 52.406% |
| Allurion Technologies Inc. | 120.57 Million USD | -6101.949% |
| Artivion, Inc. | 223.43 Million USD | -3246.85% |
| Avanos Medical, Inc. | 375.5 Million USD | -1891.478% |
| Butterfly Network, Inc. | 162.46 Million USD | -4502.809% |
| Butterfly Network, Inc. | 162.46 Million USD | -4502.809% |
| Bio-Rad Laboratories, Inc. | 1.04 Billion USD | -613.856% |
| Perspective Therapeutics, Inc. | 17.42 Million USD | -42812.889% |
| CONMED Corporation | 564.24 Million USD | -1225.318% |
| Edwards Lifesciences Corporation | 3.09 Billion USD | -141.936% |
| Paragon 28, Inc. | 210.1 Million USD | -3459.257% |
| Glaukos Corporation | 367.83 Million USD | -1932.971% |
| Globus Medical, Inc. | 887.16 Million USD | -742.914% |
| Inspire Medical Systems, Inc. | 568.49 Million USD | -1215.405% |
| Integer Holdings Corporation | 250.95 Million USD | -2879.77% |
| Medtronic plc | 16.12 Billion USD | 53.636% |
| Nevro Corp. | 389.36 Million USD | -1820.548% |
| Owlet, Inc. | 51.21 Million USD | -14500.051% |
| Penumbra, Inc. | 590.87 Million USD | -1165.576% |
| Vicarious Surgical Inc. | 80.66 Million USD | -9170.325% |
| Smith & Nephew plc | 3.46 Billion USD | -115.691% |
| Sonendo, Inc. | 68.46 Million USD | -10822.369% |
| STERIS plc | 1.4 Billion USD | -434.005% |
| Stryker Corporation | 9.2 Billion USD | 18.797% |
| Vapotherm, Inc. | 66.02 Million USD | -11226.013% |
| Zimmer Biomet Holdings, Inc. | 3.27 Billion USD | -128.266% |